DS-1001b (DS 1001)
DS-1001b (DS 1001) (S8881-GRP)
Products
Description
DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S8881 |
| Target | Dehydrogenase |